Drug shortage
Dexmedetomidine Hydrochloride Injection · Baxter Healthcare
FDA drug shortage · Current · updated Aug 17, 2026
Key facts
| Generic name | Dexmedetomidine Hydrochloride Injection |
|---|---|
| Company | Baxter Healthcare |
| Presentation | Dexmedetomidine Hydrochloride, Injection, 200 ug/50 mL (NDC 0338-9555-24) |
| Dosage form | Injection |
| Status | Current |
| Reason for shortage | Other |
| Therapeutic category | Anesthesia |
| Package NDCs | 0338-9555-24 |
| First posted | Apr 10, 2020 |
| Last updated | Aug 17, 2026 |
At a glance
- 1–9 Package NDCs affected
- 100–999 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: